SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-15-002152
Filing Date
2015-05-06
Accepted
2015-05-06 16:58:20
Documents
1
Period of Report
2015-05-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 2866
  Complete submission text file 0001354488-15-002152.txt   4378
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 884 JOHNNIE DODDS BLVD SUITE 201 MT PLEASANT SC 29464
Business Address
Drysdale Douglas (Reporting) CIK: 0001599538 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14494 | Film No.: 15837986